The ‘evidence’ of ‘no evidenceâ€â...
Alfredo . E Rodríguez

---

Risk factors and distribution of arterial obstructions ...
David Parraga Meza y cols.

---

Antiplatelet therapy in acute coronary syndromes: what ...
Luis A Guzmán

---

Percutaneous resolution of partial anomaly of left pulm...
Rodrigo Martín Egües Almeida y cols.

---

TAVI in type I bicuspid complex aortic valve with ballo...
Diego Nicolás Areco y cols.

---

Splenic complex aneurysm. Utility of 3D printing in end...
José Humberto Vicario y cols.

---

Successful evolution of endovascular treatment in a com...
Lisandro José Tesoro y cols.

---

Result of intrathrombus pharmacoinvasive endovascular t...
David Parraga Meza y cols.

---

Letter from the President of CACI
Martín Cisneros

---

Download the PDF from here

Instruction for other

Editorial

The ‘evidence’ of ‘no evidenceâ€â...
Alfredo . E Rodríguez

We have recently seen the publication of a meta-analysis1 of studies on myocardial revascularization including percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) versus optimal medical treatment (OMT) to determine if the findings of increased non-cardiac death reported in the ISCHEMIA EXTENDED study2 could be replicated in other studies. The authors reviewed 18 ra...

Artículo Original

Risk factors and distribution of arterial obstructions ...
David Parraga Meza y cols.

Given the presence and incessant growth of Critical Ischemia of the Lower Limbs (ICMI), as a result of the evolution and worsening of Peripheral Vascular Disease (PVD)1 worldwide and becoming a public health problem shortly, the Cardiovascular risk factors such as age, sedentary lifestyle, diabetes mellitus, smoking, dyslipidemia, overweight, previous coronary disease and even increased life ...

Artículo de Revisión

Antiplatelet therapy in acute coronary syndromes: what ...
Luis A Guzmán

The management of patients with acute coronary syndrome has progressed significantly over the past few decades primarily due to technological advancements made in interventional cardiology with the arrival of new drug-eluting stents, early reperfusion strategies, and a deeper understanding of anti-thrombotic therapy.The development and addition of more effective antiplatelet drugs to the ther...

Caso Clínico

Percutaneous resolution of partial anomaly of left pulm...
Rodrigo Martín Egües Almeida y cols.

Partial anomalous pulmonary venous return (PAPVR) is a rare anomaly of the pulmonary veins found in 0.5% to 0.7% of the overall population. It can have a single (to systemic veins) or dual drainage system (to the systemic atrium and left side). Various degrees of right chamber dilation occur due to chronic volume overload due to left-to-right shunting. Increased blood flow to the lungs l...

Caso Clínico

TAVI in type I bicuspid complex aortic valve with ballo...
Diego Nicolás Areco y cols.

Bicuspid aortic valve (BAV) is the most common congenital valvular heart disease and is present in almost 50% of patients eligible for aortic valve replacement. While transcatheter aortic valve implantation (TAVI) is an established treatment for severe symptomatic aortic stenosis (AS) in all levels of surgical risk, experience with TAVI in the management of severe bicuspid AS is limited and r...

Caso Clínico

Splenic complex aneurysm. Utility of 3D printing in end...
José Humberto Vicario y cols.

This is the case of a 66-year-old man with a past medical history of hypertension and the incidental finding of a splenic aneurysm on an abdominal computed tomography scan performed in the context of renal lithiasis. Anatomical evaluation was decided using percutaneous angiography and CCTA that revealed the presence of a giant 27/37 mm x 8 mm fusiform aneurysm located in the splenic hilum (Fi...

Caso Clínico

Successful evolution of endovascular treatment in a com...
Lisandro José Tesoro y cols.

Abdominal aortic aneurysm (AAA) has an incidence rate of up to 7.6% in patients older than 50 years. Risk of rupture varies depending on its diameter, ranging from approximately 10% to 20% annually for cases > 60 mm. Ideally, treatment should be performed electively during intermediate stages of its progression to prevent he acute event associated with the aneurysm (contained or free ruptu...

Comunicaciones breves

Result of intrathrombus pharmacoinvasive endovascular t...
David Parraga Meza y cols.

Acute ischemia of the lower limb is a pathology that produces a significant and dramatic reduction in blood perfusion of a lower limb as a result of the genesis of one or more thrombi lodged at any level of the limb, compromising function, viability and reaching the amputation of the affected limb if not treated on time and even cause the death of the patient, has an incidence of 1.5 cases pe...

Carta del Presidente

Letter from the President of CACI
Martín Cisneros

Dear colleagues and friends, here is the latest issue of our prestigious journal, RACI, the scientific pride and joy of CACI.The growth of RACI is the result of the effort from our entire editorial committee and each one of you who contributes to the journal valuable material for publication. We are going through challenging times in our country where medical practice is constantly ...